Cargando…
The Phenotypic Spectrum of COL4A3 Heterozygotes
INTRODUCTION: The penetrance and phenotypic spectrum of autosomal dominant Alport Syndrome (ADAS), affecting 1 in 106, remains understudied. METHODS: Using data from 174,418 participants in the Geisinger MyCode/DiscovEHR study, an unselected health system-based cohort with whole exome sequencing, we...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577321/ https://www.ncbi.nlm.nih.gov/pubmed/37849993 http://dx.doi.org/10.1016/j.ekir.2023.07.010 |
_version_ | 1785121300756299776 |
---|---|
author | Solanki, Kaushal V. Hu, Yirui Moore, Bryn S. Abedi, Vida Avula, Venkatesh Mirshahi, Tooraj Strande, Natasha T. Bucaloiu, Ion D. Chang, Alexander R. |
author_facet | Solanki, Kaushal V. Hu, Yirui Moore, Bryn S. Abedi, Vida Avula, Venkatesh Mirshahi, Tooraj Strande, Natasha T. Bucaloiu, Ion D. Chang, Alexander R. |
author_sort | Solanki, Kaushal V. |
collection | PubMed |
description | INTRODUCTION: The penetrance and phenotypic spectrum of autosomal dominant Alport Syndrome (ADAS), affecting 1 in 106, remains understudied. METHODS: Using data from 174,418 participants in the Geisinger MyCode/DiscovEHR study, an unselected health system-based cohort with whole exome sequencing, we identified 403 participants who were heterozygous for likely pathogenic COL4A3 variants. Phenotypic data was evaluated using International Classification of Diseases (ICD) codes, laboratory data, and chart review. To evaluate the phenotypic spectrum of genetically-determined ADAS, we matched COL4A3 heterozygotes 1:5 to nonheterozygotes using propensity scores by demographics, hypertension, diabetes, and nephrolithiasis. RESULTS: COL4A3 heterozygotes were at significantly increased risks of hematuria, decreased estimated glomerular filtration rate (eGFR), albuminuria, and kidney failure (P < 0.05 for all comparisons) but not bilateral sensorineural hearing loss (P = 0.9). Phenotypic severity was more severe for collagenous domain glycine missense variants than protein truncating variants (PTVs). For example, patients with Gly695Arg (n = 161) had markedly increased risk of dipstick hematuria (odds ratio [OR] 9.50; 95% confidence interval [CI]: 6.32, 14.28) and kidney failure (OR 7.02; 95% CI: 3.48, 14.16) whereas those with PTVs (n = 119) had moderately increased risks of dipstick hematuria (OR 1.64; 95% CI: 1.03, 2.59) and kidney failure (OR 3.44; 95% CI: 1.28, 9.22). Less than a third of patients had albuminuria screening completed, and fewer than 1 of 3 were taking inhibitors of the renin-angiotensin-aldosterone system. CONCLUSION: This study demonstrates a wide spectrum of phenotypic severity in ADAS due to COL4A3 with phenotypic variability by genotype. Future studies are needed to evaluate the impact of earlier diagnosis, appropriate evaluation, and treatment of ADAS. |
format | Online Article Text |
id | pubmed-10577321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105773212023-10-17 The Phenotypic Spectrum of COL4A3 Heterozygotes Solanki, Kaushal V. Hu, Yirui Moore, Bryn S. Abedi, Vida Avula, Venkatesh Mirshahi, Tooraj Strande, Natasha T. Bucaloiu, Ion D. Chang, Alexander R. Kidney Int Rep Clinical Research INTRODUCTION: The penetrance and phenotypic spectrum of autosomal dominant Alport Syndrome (ADAS), affecting 1 in 106, remains understudied. METHODS: Using data from 174,418 participants in the Geisinger MyCode/DiscovEHR study, an unselected health system-based cohort with whole exome sequencing, we identified 403 participants who were heterozygous for likely pathogenic COL4A3 variants. Phenotypic data was evaluated using International Classification of Diseases (ICD) codes, laboratory data, and chart review. To evaluate the phenotypic spectrum of genetically-determined ADAS, we matched COL4A3 heterozygotes 1:5 to nonheterozygotes using propensity scores by demographics, hypertension, diabetes, and nephrolithiasis. RESULTS: COL4A3 heterozygotes were at significantly increased risks of hematuria, decreased estimated glomerular filtration rate (eGFR), albuminuria, and kidney failure (P < 0.05 for all comparisons) but not bilateral sensorineural hearing loss (P = 0.9). Phenotypic severity was more severe for collagenous domain glycine missense variants than protein truncating variants (PTVs). For example, patients with Gly695Arg (n = 161) had markedly increased risk of dipstick hematuria (odds ratio [OR] 9.50; 95% confidence interval [CI]: 6.32, 14.28) and kidney failure (OR 7.02; 95% CI: 3.48, 14.16) whereas those with PTVs (n = 119) had moderately increased risks of dipstick hematuria (OR 1.64; 95% CI: 1.03, 2.59) and kidney failure (OR 3.44; 95% CI: 1.28, 9.22). Less than a third of patients had albuminuria screening completed, and fewer than 1 of 3 were taking inhibitors of the renin-angiotensin-aldosterone system. CONCLUSION: This study demonstrates a wide spectrum of phenotypic severity in ADAS due to COL4A3 with phenotypic variability by genotype. Future studies are needed to evaluate the impact of earlier diagnosis, appropriate evaluation, and treatment of ADAS. Elsevier 2023-07-25 /pmc/articles/PMC10577321/ /pubmed/37849993 http://dx.doi.org/10.1016/j.ekir.2023.07.010 Text en © 2023 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Clinical Research Solanki, Kaushal V. Hu, Yirui Moore, Bryn S. Abedi, Vida Avula, Venkatesh Mirshahi, Tooraj Strande, Natasha T. Bucaloiu, Ion D. Chang, Alexander R. The Phenotypic Spectrum of COL4A3 Heterozygotes |
title | The Phenotypic Spectrum of COL4A3 Heterozygotes |
title_full | The Phenotypic Spectrum of COL4A3 Heterozygotes |
title_fullStr | The Phenotypic Spectrum of COL4A3 Heterozygotes |
title_full_unstemmed | The Phenotypic Spectrum of COL4A3 Heterozygotes |
title_short | The Phenotypic Spectrum of COL4A3 Heterozygotes |
title_sort | phenotypic spectrum of col4a3 heterozygotes |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577321/ https://www.ncbi.nlm.nih.gov/pubmed/37849993 http://dx.doi.org/10.1016/j.ekir.2023.07.010 |
work_keys_str_mv | AT solankikaushalv thephenotypicspectrumofcol4a3heterozygotes AT huyirui thephenotypicspectrumofcol4a3heterozygotes AT moorebryns thephenotypicspectrumofcol4a3heterozygotes AT abedivida thephenotypicspectrumofcol4a3heterozygotes AT avulavenkatesh thephenotypicspectrumofcol4a3heterozygotes AT mirshahitooraj thephenotypicspectrumofcol4a3heterozygotes AT thephenotypicspectrumofcol4a3heterozygotes AT strandenatashat thephenotypicspectrumofcol4a3heterozygotes AT bucaloiuiond thephenotypicspectrumofcol4a3heterozygotes AT changalexanderr thephenotypicspectrumofcol4a3heterozygotes AT solankikaushalv phenotypicspectrumofcol4a3heterozygotes AT huyirui phenotypicspectrumofcol4a3heterozygotes AT moorebryns phenotypicspectrumofcol4a3heterozygotes AT abedivida phenotypicspectrumofcol4a3heterozygotes AT avulavenkatesh phenotypicspectrumofcol4a3heterozygotes AT mirshahitooraj phenotypicspectrumofcol4a3heterozygotes AT phenotypicspectrumofcol4a3heterozygotes AT strandenatashat phenotypicspectrumofcol4a3heterozygotes AT bucaloiuiond phenotypicspectrumofcol4a3heterozygotes AT changalexanderr phenotypicspectrumofcol4a3heterozygotes |